spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CollaRx 

 HSMN NewsFeed - 30 Dec 2016
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL(R) (bupivacaine HCl collagen-matrix implants) New Drug Application
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2015
Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection
Devices Wound Care
 HSMN NewsFeed - 18 Mar 2015
Innocoll AG Appoints James Tursi, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution
 HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory
 HSMN NewsFeed - 31 Mar 2009
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
Devices Wound Care
 HSMN NewsFeed - 17 Nov 2008
Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant
Devices Drug Delivery FDA
 HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 9 May 2008
EUSA Pharma Completes Acquisition Of Cytogen Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2008
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2008
ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe
Biopharmaceuticals Regulatory Drug Delivery
 HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management
 HSMN NewsFeed - 2 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Devices Surgery
 HSMN NewsFeed - 18 Dec 2007
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 17 Oct 2007
Innocoll Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 6 Sep 2007
Innocoll, Inc. and Bourne Partners Announce Joint Venture to Build Leading U.S. Advanced Wound Care Business
Devices Wound Care
 HSMN NewsFeed - 6 Sep 2007
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Biopharmaceuticals Surgery Acquisitions
 HSMN NewsFeed - 8 Aug 2007
Health Canada Approves Innocoll's CollaRx(R) GENTAMICIN SURGICAL IMPLANT
Devices Regulatory
 HSMN NewsFeed - 6 Jun 2007
Innocoll Announces Filing of Investigational New Drug Application for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 Apr 2007
Innocoll Announces Outcome of FDA Meeting to Commence Phase 3 Development of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Devices Surgery FDA
 HSMN NewsFeed - 4 Apr 2007
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 29 Mar 2007
Innocoll Files US and Irish Patent Applications for its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 22 Mar 2007
Innocoll Files CollaRx(R) GENTAMICIN SURGICAL IMPLANT in Canada and Receives Canadian Medical Devices Conformity Assessment System (CMDCAS) Certification
Devices Regulatory
 HSMN NewsFeed - 5 Feb 2007
Innocoll Receives BfArM Approval for a New Version of its CollaRx(R) Gentamicin Surgical Implant in Germany
Devices Surgery Regulatory
 HSMN NewsFeed - 22 Jan 2007
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers with Its CollaRx(R) GENTAMICIN
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jan 2007
Innocoll Announces Expansion of Distribution Partnership for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT With BurnsAdler to Include Brazil and Dominican Republic and a Separate Promotional Agreement Between BurnsAdler and Serral for Same Product in Mexico
Devices Distribution
 HSMN NewsFeed - 9 Nov 2006
Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 Oct 2006
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
Devices Wound Care
Return to NewsFeed  

 Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 12 additional stories matching:
CollaRx
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.